Clearance Summary
LoFric Origo Pro Coudé received FDA 510(k) clearance under submission number K261658, sponsored by Wellspect AB. The device was reviewed via the Special premarket notification pathway and assigned to the Gastroenterology, Urology review panel. The statutory decision date of record is 2026-07-17.
- Submission: K261658
- Applicant / Sponsor: Wellspect AB
- Clearance pathway: Special
- Review panel: Gastroenterology, Urology
- Device class: Class II
- Regulation citation: 21 CFR 876.5130
- Decision date: 2026-07-17
Classification & Regulation
This clearance is catalogued under FDA product code EZD and 21 CFR 876.5130, within the Gastroenterology, Urology review panel as a Class II device.